Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net earnings	$ 168	$ 405	$ 154
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	85	65	58
Deferred income taxes	(52)	(6)	31
Gain from sale of business	0	(354)	0
Share-based compensation expense	17	5	0
Other	1	0	0
Changes in assets and liabilities:
Accounts receivable	15	(1)	(54)
Contract assets	(36)	(134)	(71)
Inventories	(10)	(33)	42
Prepaid expenses	(1)	(1)	10
Other current assets	(18)	3	12
Other noncurrent assets	19	24	19
Defined benefit obligations	(8)	(4)	(13)
Other current liabilities	(26)	14	28
Other noncurrent liabilities	8	(8)	(36)
Accounts payable	(59)	(14)	1
Contract liabilities	102	72	(3)
Net cash provided by operating activities	205	33	178
Investing activities
Capital expenditures	(60)	(65)	(60)
Business acquisitions, net of cash acquired	0	19	(14)
Proceeds from sales of assets	1	0	0
Proceeds from sales of businesses	0	482	0
Net repayments received on related party note receivable	0	0	115
Cost method investment	0	0	(2)
Net cash (used in) provided by investing activities	(59)	436	39
Financing activities
Net increase (decrease) in third party borrowings (maturities of 90 days or less)	20	(8)	(18)
Repayment of third party debt	(727)	0	0
Borrowings of third party debt	715	223	0
Repayment of related party debt	0	(992)	(950)
Borrowings from related parties	0	775	930
Dividend to US Holding	0	(396)	0
Dividend from investment	0	3	0
Proceeds from stock issuance	12	0	0
Cash outlay to reacquire equity instruments	(1)	0	0
Other	(4)	(8)	0
Net cash provided by (used in) financing activities	15	(403)	(38)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Net increase in cash and cash equivalents	161	66	179
Cash and cash equivalents at beginning of year	306	240	61
Cash and cash equivalents at end of period	$ 467	$ 306	$ 240